MS Speaks

Multiple Sclerosis => TREATMENTS => LEMTRADA (Campath, alemtuzumab) => Topic started by: agate on July 23, 2018, 07:49:08 pm

Title: (Abst.) Neutropenia w/fatal outcome in MS patient 23 days after alemtuzumab infusion
Post by: agate on July 23, 2018, 07:49:08 pm

From Multiple Sclerosis and Related Disorders (July 2018), "Neutropenia with fatal outcome in a multiple sclerosis patient 23 days after alemtuzumab infusion":


https://www.msard-journal.com/article/S2211-0348(18)30133-0/abstract